| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 16.624 | 20.999 | 27.486 | 49.895 | 49.079 | 73.463 | 80.638 | 79.772 | 99.885 | 81.502 |
| Total Income - EUR | 16.624 | 20.999 | 27.486 | 49.895 | 49.079 | 73.696 | 80.638 | 79.772 | 101.098 | 91.554 |
| Total Expenses - EUR | 16.880 | 16.942 | 24.411 | 38.600 | 39.038 | 68.097 | 88.444 | 94.926 | 99.326 | 87.734 |
| Gross Profit/Loss - EUR | -256 | 4.058 | 3.076 | 11.295 | 10.041 | 5.599 | -7.806 | -15.153 | 1.772 | 3.820 |
| Net Profit/Loss - EUR | -755 | 3.427 | 2.251 | 9.798 | 8.568 | 4.222 | -8.612 | -15.935 | 781 | 1.966 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Giulpharm Distribution S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.782 | 2.826 | 1.646 | 1.678 | 2.014 | 10.118 | 8.462 | 5.297 | 1.679 | 2.870 |
| Current Assets | 4.561 | 7.287 | 10.872 | 20.106 | 21.535 | 24.481 | 34.670 | 43.940 | 48.206 | 50.595 |
| Inventories | 2.746 | 4.637 | 5.184 | 6.267 | 8.398 | 15.187 | 19.044 | 23.416 | 23.158 | 25.161 |
| Receivables | 1.726 | 2.521 | 4.377 | 8.346 | 3.081 | 4.229 | 14.486 | 19.597 | 24.446 | 23.802 |
| Cash | 89 | 128 | 1.311 | 5.493 | 10.056 | 5.066 | 1.141 | 926 | 601 | 1.631 |
| Shareholders Funds | -2.767 | 688 | 2.928 | 12.672 | 20.995 | 24.819 | 15.656 | -230 | 552 | 2.514 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 9.110 | 9.425 | 9.590 | 9.111 | 2.553 | 9.780 | 27.476 | 49.467 | 49.333 | 50.951 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Giulpharm Distribution S.r.l.